Suppr超能文献

腺癌细胞系单细胞异质性分析及肿瘤内异质性研究揭示跨膜蛋白45A(TMEM45A)在肺腺癌患者中的表达

Analysis of the Single-Cell Heterogeneity of Adenocarcinoma Cell Lines and the Investigation of Intratumor Heterogeneity Reveals the Expression of Transmembrane Protein 45A (TMEM45A) in Lung Adenocarcinoma Cancer Patients.

作者信息

Neuperger Patrícia, Balog József Á, Tiszlavicz László, Furák József, Gémes Nikolett, Kotogány Edit, Szalontai Klára, Puskás László G, Szebeni Gábor J

机构信息

Laboratory of Functional Genomics, Biological Research Centre, Temesvári krt. 62, H6726 Szeged, Hungary.

Ph.D. School in Biology, University of Szeged, H6726 Szeged, Hungary.

出版信息

Cancers (Basel). 2021 Dec 29;14(1):144. doi: 10.3390/cancers14010144.

Abstract

Intratumoral heterogeneity (ITH) is responsible for the majority of difficulties encountered in the treatment of lung-cancer patients. Therefore, the heterogeneity of NSCLC cell lines and primary lung adenocarcinoma was investigated by single-cell mass cytometry (CyTOF). First, we studied the single-cell heterogeneity of frequent NSCLC adenocarcinoma models, such as A549, H1975, and H1650. The intra- and inter-cell-line single-cell heterogeneity is represented in the expression patterns of 13 markers-namely GLUT1, MCT4, CA9, TMEM45A, CD66, CD274 (PD-L1), CD24, CD326 (EpCAM), pan-keratin, TRA-1-60, galectin-3, galectin-1, and EGFR. The qRT-PCR and CyTOF analyses revealed that a hypoxic microenvironment and altered metabolism may influence cell-line heterogeneity. Additionally, human primary lung adenocarcinoma and non-involved healthy lung tissue biopsies were homogenized to prepare a single-cell suspension for CyTOF analysis. The CyTOF showed the ITH of human primary lung adenocarcinoma for 14 markers; particularly, the higher expressions of GLUT1, MCT4, CA9, TMEM45A, and CD66 were associated with the lung-tumor tissue. Our single-cell results are the first to demonstrate TMEM45A expression in human lung adenocarcinoma, which was verified by immunohistochemistry.

摘要

肿瘤内异质性(ITH)是肺癌患者治疗中遇到的大多数困难的原因。因此,通过单细胞质谱流式细胞术(CyTOF)研究了非小细胞肺癌(NSCLC)细胞系和原发性肺腺癌的异质性。首先,我们研究了常见的NSCLC腺癌模型(如A549、H1975和H1650)的单细胞异质性。细胞内和细胞间的单细胞异质性体现在13种标志物的表达模式中,即葡萄糖转运蛋白1(GLUT1)、单羧酸转运蛋白4(MCT4)、碳酸酐酶9(CA9)、跨膜蛋白45A(TMEM45A)、CD66、CD274(程序性死亡受体配体1,PD-L1)、CD24、上皮细胞黏附分子(CD326,EpCAM)、泛角蛋白、TRA-1-60、半乳糖凝集素-3、半乳糖凝集素-1和表皮生长因子受体(EGFR)。定量逆转录聚合酶链反应(qRT-PCR)和CyTOF分析表明,低氧微环境和代谢改变可能影响细胞系异质性。此外,将人原发性肺腺癌和未受累的健康肺组织活检样本匀浆,制备单细胞悬液用于CyTOF分析。CyTOF显示了人原发性肺腺癌14种标志物的ITH;特别是,GLUT1、MCT4、CA9、TMEM45A和CD66的高表达与肺肿瘤组织相关。我们的单细胞研究结果首次证明了跨膜蛋白45A在人肺腺癌中的表达,这通过免疫组织化学得到了验证。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6a3/8750076/0c7d191f2f16/cancers-14-00144-g001.jpg

相似文献

6
Antiproliferative and antimetastatic characterization of an exo-heterocyclic androstane derivative against human breast cancer cell lines.
Biomed Pharmacother. 2021 Aug;140:111728. doi: 10.1016/j.biopha.2021.111728. Epub 2021 May 19.
9
Intratumor Heterogeneity of ALK-Rearrangements and Homogeneity of EGFR-Mutations in Mixed Lung Adenocarcinoma.
PLoS One. 2015 Sep 30;10(9):e0139264. doi: 10.1371/journal.pone.0139264. eCollection 2015.

引用本文的文献

2
Characterization of obesity-related diseases and inflammation using single cell immunophenotyping in two different diet-induced obesity models.
Int J Obes (Lond). 2024 Nov;48(11):1568-1576. doi: 10.1038/s41366-024-01584-6. Epub 2024 Jul 14.
3
Peripheral immunophenotyping reveals lymphocyte stimulation in healthy women living with hereditary breast and ovarian cancer syndrome.
iScience. 2024 May 4;27(6):109882. doi: 10.1016/j.isci.2024.109882. eCollection 2024 Jun 21.
6
9
Introduction of an Ultraviolet C-Irradiated 4T1 Murine Breast Cancer Whole-Cell Vaccine Model.
Vaccines (Basel). 2023 Jul 18;11(7):1254. doi: 10.3390/vaccines11071254.
10
Advances in Mass Spectrometry-Based Single Cell Analysis.
Biology (Basel). 2023 Mar 2;12(3):395. doi: 10.3390/biology12030395.

本文引用的文献

4
HIF-α Prolyl Hydroxylase Inhibitors and Their Implications for Biomedicine: A Comprehensive Review.
Biomedicines. 2021 Apr 24;9(5):468. doi: 10.3390/biomedicines9050468.
5
Characterizing genetic intra-tumor heterogeneity across 2,658 human cancer genomes.
Cell. 2021 Apr 15;184(8):2239-2254.e39. doi: 10.1016/j.cell.2021.03.009. Epub 2021 Apr 7.
6
Tumor Heterogeneity: A Great Barrier in the Age of Cancer Immunotherapy.
Cancers (Basel). 2021 Feb 15;13(4):806. doi: 10.3390/cancers13040806.
9
Drivers of dynamic intratumor heterogeneity and phenotypic plasticity.
Am J Physiol Cell Physiol. 2021 May 1;320(5):C750-C760. doi: 10.1152/ajpcell.00575.2020. Epub 2021 Mar 3.
10
Nongenetic Evolution Drives Lung Adenocarcinoma Spatial Heterogeneity and Progression.
Cancer Discov. 2021 Jun;11(6):1490-1507. doi: 10.1158/2159-8290.CD-20-1274. Epub 2021 Feb 9.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验